IP Library › Assignment 055648/0491
Patent Assignment
Reel/Frame 055648/0491

Assignment of Assignor's Interest

Recorded: 2021-03-19 Pages: 12
Assignor
ALNYLAM PHARMACEUTICALS, INC.
Executed: 2012-12-05
Assignee
TEKMIRA PHARMACEUTICALS CORPORATION
100 - 8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property (1)
Lipid Containing Formulations
Application: 16/713,712 →
Publication: US 2020/0361854
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 17, 2021
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; AKINC, AKIN; NAIR, JAYAPRAKASH K.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 055626/0896 →
Change of Name Mar 22, 2022
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 059337/0845 →
Merger Mar 23, 2022
From: PROTIVA BIOTHERAPEUTICS, INC.
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 061086/0886 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →